These molecules can directly or indirectly regulate the PI3K/Akt/mTOR pathway through a variety of ways, thereby affecting the proliferation, metastasis, chemoradiotherapy sensitivity and angiogenesis of ESCC. This evidence concerns the gene PIK3CA and esophageal squamous cell carcinoma.